Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
313.00
+7.29 (2.38%)
May 11, 2026, 10:30 AM EDT - Market open

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23
Product Revenue, Net
417.30M389.13M290.52M
Product Revenue, Net Growth
7.24%33.95%473.02%
Revenue (Total)
417.30M389.13M290.52M
Revenue (Total) Growth
7.24%33.95%473.02%
Updated May 4, 2026. Data Source: Fiscal.ai.